Clinical Disease Activity With Long Term Natalizumab Treatment

NCT02677077 · clinicaltrials.gov ↗

COMPLETED

Status

277

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis

Interventions

DRUG: natalizumab

Sponsor

Biogen